News Roche takes on development of potential Huntington’s breakth... Ionis has completed its licensing agreement with Roche for IONIS-HTTRx, a drug which could be a breakthrough in treating Huntington’s disease.
News Huntington's Disease wearable gets backing from NIH BioSensics' HDWear provides real-time motor function scores in Huntington's patients.
News FDA approves Teva's Huntington's Disease drug First treatment approved for Huntington's Disease in almost a decade.
News Teva files orphan blockbuster hope in tardive dyskinesia SD-809 will be vital for Teva if approved.
News Teva collaborates with Intel to develop Huntington's smartwa... Teva enters the machine learning market.
Oncology In pursuit of a cure for cancer: An ASCO 2025 discussion wit... Dr Danny Nguyen, medical oncologist and haematologist at the City of Hope Orange County, spoke with pharmaphorum at ASCO 2025.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face